Punit Dhillon - Net Worth and Insider Trading

Punit Dhillon Net Worth

The estimated net worth of Punit Dhillon is at least $2 Million dollars as of 2024-04-30. Punit Dhillon is the CEO of Skye Bioscience Inc and owns about 166,219 shares of Skye Bioscience Inc (SKYE) stock worth over $2 Million. Punit Dhillon is also the Director of OncoSec Medical Inc and owns about 2,206 shares of OncoSec Medical Inc (ONCSQ) stock worth over $1. Details can be seen in Punit Dhillon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Punit Dhillon has not made any transactions after 2023-08-29 and currently still holds the listed stock(s).

Transaction Summary of Punit Dhillon

To

Punit Dhillon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Punit Dhillon owns 4 companies in total, including Skye Bioscience Inc (SKYE) , Arch Therapeutics Inc (ARTH) , and OncoSec Medical Inc (ONCSQ) among others .

Click here to see the complete history of Punit Dhillon’s form 4 insider trades.

Insider Ownership Summary of Punit Dhillon

Ticker Comapny Transaction Date Type of Owner
SKYE Skye Bioscience Inc 2023-08-29 director
ARTH Arch Therapeutics Inc 2019-12-20 director
ONCSQ OncoSec Medical Inc 2018-07-05 President and CEO
INO Inovio Pharmaceuticals Inc 2008-01-30 VP & Finance & Operations

Punit Dhillon Latest Holdings Summary

Punit Dhillon currently owns a total of 2 stocks. Among these stocks, Punit Dhillon owns 166,219 shares of Skye Bioscience Inc (SKYE) as of August 29, 2023, with a value of $2 Million and a weighting of 100%. Punit Dhillon also owns 2,206 shares of OncoSec Medical Inc (ONCSQ) as of July 5, 2018, with a value of $1 and a weighting of 0%.

Latest Holdings of Punit Dhillon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SKYE Skye Bioscience Inc 2023-08-29 166,219 13.00 2,160,847
ONCSQ OncoSec Medical Inc 2018-07-05 2,206 0.00 1

Holding Weightings of Punit Dhillon


Punit Dhillon Form 4 Trading Tracker

According to the SEC Form 4 filings, Punit Dhillon has made a total of 3 transactions in Skye Bioscience Inc (SKYE) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Skye Bioscience Inc is the acquisition of 3,524 shares on August 29, 2023, which cost Punit Dhillon around $17,620.

According to the SEC Form 4 filings, Punit Dhillon has made a total of 0 transactions in OncoSec Medical Inc (ONCSQ) over the past 5 years. The most-recent trade in OncoSec Medical Inc is the sale of 1,002 shares on July 5, 2018, which brought Punit Dhillon around $304,207.

Insider Trading History of Punit Dhillon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Punit Dhillon Trading Performance

GuruFocus tracks the stock performance after each of Punit Dhillon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Punit Dhillon is -22.39%. GuruFocus also compares Punit Dhillon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Punit Dhillon within 3 months outperforms 2 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Punit Dhillon's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Punit Dhillon

Average Return

8.47%

Average return per transaction

Outperforming Transactions

43%

3 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.14 -22.39 67.47 8.47 -38.18 -33.8
Relative Return to S&P 500(%) -1.95 -22.17 59.06 -4.35 -48.87 -44.9

Punit Dhillon Ownership Network

Ownership Network List of Punit Dhillon

No Data

Ownership Network Relation of Punit Dhillon


Punit Dhillon Owned Company Details

What does Skye Bioscience Inc do?

Who are the key executives at Skye Bioscience Inc?

Punit Dhillon is the director of Skye Bioscience Inc. Other key executives at Skye Bioscience Inc include 10 percent owner 5am Partners Vii, Llc , 10 percent owner John D Diekman , and 10 percent owner 5am Ventures Vii, L.p. .

Skye Bioscience Inc (SKYE) Insider Trades Summary

Over the past 18 months, Punit Dhillon made 2 insider transaction in Skye Bioscience Inc (SKYE) with a net purchase of 1,762,000. Other recent insider transactions involving Skye Bioscience Inc (SKYE) include a net purchase of 5,656,074 shares made by 5am Partners Vii, Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Skye Bioscience Inc (SKYE) in total and bought 5,656,074 shares, with a net purchase of 5,656,074 shares. During the past 18 months, 0 shares of Skye Bioscience Inc (SKYE) were sold and 5,663,122 shares were bought by its insiders, resulting in a net purchase of 5,663,122 shares.

Skye Bioscience Inc (SKYE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Skye Bioscience Inc Insider Transactions

No Available Data

Punit Dhillon Mailing Address

Above is the net worth, insider trading, and ownership report for Punit Dhillon. You might contact Punit Dhillon via mailing address: 5820 Nancy Ridge Drive, San Diego Ca 92121.

Discussions on Punit Dhillon

No discussions yet.